Ally Financial’s Eli Lilly LLY Stock Holding History

Ally Financial’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.82M	Buy	8,500 +4,500	+113%	+$4.56M	0.97%	22
2025 Q4	$4.3M	Sell	4,000 -15,000	-79%	-$14.3M	0.52%	42
2025 Q3	$14.5M	Buy	19,000 +4,000	+27%	+$2.98M	1.79%	8
2025 Q2	$11.7M	Buy	15,000 +2,000	+15%	+$1.55M	1.32%	12
2025 Q1	$10.7M	Buy	13,000 +4,000	+44%	+$3.33M	1.2%	17
2024 Q4	$6.95M	Buy	9,000 +7,000	+350%	+$5.8M	0.85%	24
2024 Q3	$1.77M	Buy	+2,000	New	+$1.8M	0.21%	77
2018 Q3	–	Sell	-15,000	Closed	-$1.28M	–	119
2018 Q2	$1.28M	Hold	15,000	–	–	0.25%	93
2018 Q1	$1.16M	Buy	+15,000	New	+$1.21M	0.17%	107
2017 Q1	–	Sell	-35,000	Closed	-$2.57M	–	114
2016 Q4	$2.57M	Buy	35,000 +15,000	+75%	+$1.12M	0.43%	62
2016 Q3	$1.6M	Hold	20,000	–	–	0.28%	81
2016 Q2	$1.57M	Hold	20,000	–	–	0.26%	97
2016 Q1	$1.44M	Buy	+20,000	New	+$1.51M	0.2%	114
2014 Q2	–	Sell	-100,000	Closed	-$5.89M	–	139
2014 Q1	$5.89M	Hold	100,000	–	–	0.63%	53
2013 Q4	$5.1M	Hold	100,000	–	–	0.54%	74
2013 Q3	$5.03M	Hold	100,000	–	–	0.55%	68
2013 Q2	$4.91M	Buy	+100,000	New	+$5.44M	0.48%	84

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ally Financial's LLY Position: Q1 2026 in Review

Ally Financial increased its Eli Lilly (LLY) stake by 113% in Q1 2026, buying an estimated $4.56M and bringing the position to 8,500 shares worth $7.82M. The position accounts for 0.97% of the portfolio, ranked #22.

Ally Financial first reported a position in LLY in Q2 2013 and has held it in 17 quarters since. The position peaked at $14.5M in Q3 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Ally Financial held 8,500 shares of Eli Lilly worth $7.82M as of Q1 2026.
Ally Financial bought 4,500 Eli Lilly shares in Q1 2026, an estimated $4.56M.
Eli Lilly made up 0.97% of Ally Financial's portfolio in Q1 2026, its #22 holding.
Ally Financial first reported a position in Eli Lilly in Q2 2013 and has held it in 17 quarters since.
Ally Financial's Eli Lilly position peaked at $14.5M in Q3 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ally Financial's 13F filing for Q1 2026, filed 12 May 2026.